Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001121404-24-000020
Filing Date
2024-10-25
Accepted
2024-10-25 12:39:21
Documents
4
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 6-K a6kcoverpagepressreleaseq3.htm 6-K 13027
2 EX-99.1 pressreleaseq32024english.htm EX-99.1 988287
3 GRAPHIC image.jpg GRAPHIC 102900
4 GRAPHIC image1.jpg GRAPHIC 4047
  Complete submission text file 0001121404-24-000020.txt   1150091
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 241395878
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)